(CNN) -- Three top secret, experimental vials stored at subzero
temperatures were flown into Liberia last week in a last-ditch effort to
save the American missionary workers who had contracted Ebola,
according to a source familiar with details of the treatment.
A
representative from the National Institutes of Health contacted
Samaritan's Purse, the aid organization both Dr. Kent Brantly and Nancy
Writebol worked for in Liberia, and offered up the experimental
treatment, known as ZMapp, according to the source.
The drug was
developed by the biotech firm Mapp Biopharmaceutical Inc. The patients
were told that this treatment had never been tried before in a human
being, but had shown promise in small experiments with monkeys.
According
to company documents, four monkeys infected with Ebola and then given
the therapy within 24 hours had survived. Two of four monkeys that
started therapy within 48 hours also survived, while one that was not
treated died within five days of exposure.
No comments:
Post a Comment